ETON
Price
$14.45
Change
-$0.03 (-0.21%)
Updated
Jul 3 closing price
Capitalization
96.33M
34 days until earnings call
LBTSF
Price
$13.36
Change
+$4.35 (+48.28%)
Updated
Jun 26 closing price
Capitalization
2.01B
Interact to see
Advertisement

ETON vs LBTSF

Header iconETON vs LBTSF Comparison
Open Charts ETON vs LBTSFBanner chart's image
Eton Pharmaceuticals
Price$14.45
Change-$0.03 (-0.21%)
Volume$243.26K
Capitalization96.33M
Almirall SA
Price$13.36
Change+$4.35 (+48.28%)
Volume$332
Capitalization2.01B
ETON vs LBTSF Comparison Chart in %
Loading...
ETON
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
LBTSF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
ETON vs. LBTSF commentary
Jul 04, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is ETON is a Hold and LBTSF is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jul 04, 2025
Stock price -- (ETON: $14.45 vs. LBTSF: $13.36)
Brand notoriety: ETON and LBTSF are both not notable
Both companies represent the Pharmaceuticals: Other industry
Current volume relative to the 65-day Moving Average: ETON: 54% vs. LBTSF: 237%
Market capitalization -- ETON: $96.33M vs. LBTSF: $2.01B
ETON [@Pharmaceuticals: Other] is valued at $96.33M. LBTSF’s [@Pharmaceuticals: Other] market capitalization is $2.01B. The market cap for tickers in the [@Pharmaceuticals: Other] industry ranges from $77.48B to $0. The average market capitalization across the [@Pharmaceuticals: Other] industry is $3.8B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

ETON’s FA Score shows that 1 FA rating(s) are green whileLBTSF’s FA Score has 1 green FA rating(s).

  • ETON’s FA Score: 1 green, 4 red.
  • LBTSF’s FA Score: 1 green, 4 red.
According to our system of comparison, ETON is a better buy in the long-term than LBTSF.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

ETON’s TA Score shows that 5 TA indicator(s) are bullish while LBTSF’s TA Score has 0 bullish TA indicator(s).

  • ETON’s TA Score: 5 bullish, 5 bearish.
  • LBTSF’s TA Score: 0 bullish, 2 bearish.
According to our system of comparison, ETON is a better buy in the short-term than LBTSF.

Price Growth

ETON (@Pharmaceuticals: Other) experienced а +3.51% price change this week, while LBTSF (@Pharmaceuticals: Other) price change was 0.00% for the same time period.

The average weekly price growth across all stocks in the @Pharmaceuticals: Other industry was +2.13%. For the same industry, the average monthly price growth was +3.08%, and the average quarterly price growth was +93.03%.

Reported Earning Dates

ETON is expected to report earnings on Aug 07, 2025.

Industries' Descriptions

@Pharmaceuticals: Other (+2.13% weekly)

Pharmaceuticals (Other) comprise companies that are involved in the discovery, development or manufacturing of therapeutic and preventative medicines. They often collaborate with or acquire other pharmaceutical/healthcare firms. Examples of companies in this segment include Bausch Health Companies Inc., Icon Plc and Perrigo Company Plc.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
LBTSF($2.01B) has a higher market cap than ETON($96.3M). LBTSF (49.75) and ETON (49.33) have similar P/E ratio . LBTSF YTD gains are higher at: 45.645 vs. ETON (8.483). LBTSF has higher annual earnings (EBITDA): 150M vs. ETON (-291K). LBTSF has more cash in the bank: 447M vs. ETON (21.4M). ETON has less debt than LBTSF: ETON (5.4M) vs LBTSF (398M). LBTSF has higher revenues than ETON: LBTSF (893M) vs ETON (31.6M).
ETONLBTSFETON / LBTSF
Capitalization96.3M2.01B5%
EBITDA-291K150M-0%
Gain YTD8.48345.64519%
P/E Ratio49.3349.7599%
Revenue31.6M893M4%
Total Cash21.4M447M5%
Total Debt5.4M398M1%
FUNDAMENTALS RATINGS
ETON vs LBTSF: Fundamental Ratings
ETON
LBTSF
OUTLOOK RATING
1..100
942
VALUATION
overvalued / fair valued / undervalued
1..100
85
Overvalued
33
Fair valued
PROFIT vs RISK RATING
1..100
3877
SMR RATING
1..100
9487
PRICE GROWTH RATING
1..100
3736
P/E GROWTH RATING
1..100
493
SEASONALITY SCORE
1..100
5055

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

LBTSF's Valuation (33) in the null industry is somewhat better than the same rating for ETON (85) in the Pharmaceuticals Major industry. This means that LBTSF’s stock grew somewhat faster than ETON’s over the last 12 months.

ETON's Profit vs Risk Rating (38) in the Pharmaceuticals Major industry is somewhat better than the same rating for LBTSF (77) in the null industry. This means that ETON’s stock grew somewhat faster than LBTSF’s over the last 12 months.

LBTSF's SMR Rating (87) in the null industry is in the same range as ETON (94) in the Pharmaceuticals Major industry. This means that LBTSF’s stock grew similarly to ETON’s over the last 12 months.

LBTSF's Price Growth Rating (36) in the null industry is in the same range as ETON (37) in the Pharmaceuticals Major industry. This means that LBTSF’s stock grew similarly to ETON’s over the last 12 months.

ETON's P/E Growth Rating (4) in the Pharmaceuticals Major industry is significantly better than the same rating for LBTSF (93) in the null industry. This means that ETON’s stock grew significantly faster than LBTSF’s over the last 12 months.

TECHNICAL ANALYSIS
Technical Analysis
ETONLBTSF
RSI
ODDS (%)
Bullish Trend 1 day ago
90%
Bearish Trend 1 day ago
17%
Stochastic
ODDS (%)
Bearish Trend 1 day ago
82%
Bearish Trend 1 day ago
15%
Momentum
ODDS (%)
Bullish Trend 1 day ago
82%
N/A
MACD
ODDS (%)
Bullish Trend 1 day ago
76%
N/A
TrendWeek
ODDS (%)
Bullish Trend 1 day ago
80%
Bullish Trend 1 day ago
13%
TrendMonth
ODDS (%)
Bearish Trend 1 day ago
80%
Bullish Trend 1 day ago
13%
Advances
ODDS (%)
Bullish Trend 4 days ago
82%
N/A
Declines
ODDS (%)
Bearish Trend 17 days ago
80%
N/A
BollingerBands
ODDS (%)
Bullish Trend 1 day ago
88%
N/A
Aroon
ODDS (%)
Bearish Trend 1 day ago
79%
N/A
View a ticker or compare two or three
Interact to see
Advertisement
ETON
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
LBTSF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
MFs / NAMEPrice $Chg $Chg %
DEMGX12.710.13
+1.03%
DFA Emerging Markets Trgt Val Instl
VAFFX33.44N/A
N/A
Invesco American Franchise R6
CDGCX15.06N/A
N/A
Crawford Large Cap Dividend C
CRRYX14.49N/A
N/A
Columbia Small Cap Value II Inst3
CIVAX19.46-0.01
-0.05%
American Funds International Vntg 529-A

ETON and

Correlation & Price change

A.I.dvisor indicates that over the last year, ETON has been loosely correlated with MDGL. These tickers have moved in lockstep 34% of the time. This A.I.-generated data suggests there is some statistical probability that if ETON jumps, then MDGL could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To ETON
1D Price
Change %
ETON100%
-0.21%
MDGL - ETON
34%
Loosely correlated
-0.43%
VKTX - ETON
31%
Poorly correlated
+1.70%
LBTSF - ETON
30%
Poorly correlated
N/A
ARRY - ETON
30%
Poorly correlated
+11.93%
FDMT - ETON
29%
Poorly correlated
-1.62%
More

LBTSF and

Correlation & Price change

A.I.dvisor indicates that over the last year, LBTSF has been loosely correlated with HLTRF. These tickers have moved in lockstep 39% of the time. This A.I.-generated data suggests there is some statistical probability that if LBTSF jumps, then HLTRF could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To LBTSF
1D Price
Change %
LBTSF100%
N/A
HLTRF - LBTSF
39%
Loosely correlated
N/A
ETON - LBTSF
30%
Poorly correlated
-0.21%
INDV - LBTSF
18%
Poorly correlated
+0.06%
IPSEY - LBTSF
15%
Poorly correlated
N/A
MEDXF - LBTSF
10%
Poorly correlated
-1.27%
More